Home » Topics » BioWorld Science

BioWorld Science
RSS

NexImmune partners with Zephyr AI to discover novel targets for T-cell-mediated therapies for cancer

March 18, 2022

Soligenix reports CiVax booster vaccination findings

March 18, 2022

3,6'-Dithiopomalidomide shows promise for treating AD

March 18, 2022

Food-borne bacterium's neuroinvasion mechanism discovered

March 18, 2022

Ceftibuten/VNRX-7145 shows efficacy against Enterobacterales carrying common serine beta-lactamases

March 18, 2022

WTX-124, a conditionally activated IL-2 prodrug with minimized toxicity in cancer models

March 18, 2022

Novel mesothelin-targeted TriKE antibody against NSCLC

March 18, 2022

Removal of S protein glycan shields yields broadly protective SARS-CoV-2 vaccine

March 18, 2022

Researchers describe new ghrelin receptor GHSR1a ligand to modulate brain dopamine

March 18, 2022

Johns Hopkins University and IOCB of the ASCR patent 6-MP prodrugs

March 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...